Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.French pharmaceutical and cosmetics firm Pierre Fabre Laboratories has selected Ireland-based QUMAS' compliance platform DocCompliance to manage and control quality documents across the entire company.
Subscribe to our email newsletter
The platform was selected after an extensive evaluation process carried out by members of the Quality Assurance and IT teams at Pierre.
Initially, the QUMAS solution will be rolled out to about 3,850 employees at Pierre Fabre.
The solution offers Pierre with a complete web-based electronic document management system that allows users to create, manage, circulate and securely store all documents and content related to quality assurance and quality control across the company’s product portfolio.
It fully supports Electronic Signatures as per the FDA 21 CFR Part 11 requirements and is configurable, enabling companies to mirror their organizational structures and practices.
The company said that all of the compliance capabilities of the platform are accessed through MyQUMAS, a user-friendly web-based interface.
QUMAS CEO Kevin O’Leary said the company provides Pierre Fabre with a scalable solution that will allow employees across all of its product sites to collaborate on quality assurance content and documents in a controlled, compliant and fully auditable manner.
"We are delighted to be adding another leading French company to our client list, and plan to increase our client base in Europe significantly this year," O’Leary said.
Pierre Fabre Laboratories business project director Pierre Contreras said the company conducted a very thorough evaluation of a number of vendor solutions.
"We were very impressed with the advanced features of DocCompliance and its large reference base of companies across our industry, as well as the professionalism and responsiveness of the QUMAS team," Contreras said.